Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 111-120 of 171 for Prostate cancer

Edit search filters
  1. Hypofractionated Radiation Therapy Or Conventional Radiation Therapy After Surgery In Treating Patients With Prostate Cancer

    Albert Lea, MN, Eau Claire, WI, Jacksonville, FL, La Crosse, WI, Mankato, MN, Rochester, MN

  2. A Study Comparing Orteronel Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer, Who Have Not Had Chemotherapy

    Jacksonville, FL, Rochester, MN

  3. Once-daily Oral VT-464 In Patients With Castration-Resistant Prostate Cancer Progressing On Enzalutamide Or Abiraterone.

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  4. A Study Of GSK5458514 Administered Alone Or In Combination With Other Anti-Cancer Agents In Participants With Prostate Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. Controlled Low Calorie Diet In Reducing Side Effects And Increasing Response To Chemotherapy In Patients With Breast Or Prostate Cancer

    Rochester, MN

  6. Phase III Study Of DCVAC Added To Standard Chemotherapy For Men With Metastatic Castration Resistant Prostate Cancer

    Scottsdale/Phoenix, AZ

  7. A Study Of Rucaparib In Patients With Metastatic Castration-resistant Prostate Cancer And Homologous Recombination Gene Deficiency

    Scottsdale/Phoenix, AZ

  8. The Role Of Highly Selective Androgen Receptor (AR) Targeted Therapy In Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

    Scottsdale/Phoenix, AZ

  9. Study To Evaluate 99mTc-MIP-1404 SPECT/CT Imaging In Men With Biopsy Proven Low-Grade Prostate Cancer

    Rochester, MN

  10. A Study Using Gallium-68 PSMA-11 And C-11 Choline PET Imaging To Detect Metastatic Prostate Cancer In Patients

    Rochester, MN

.

Mayo Clinic Footer